B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 6.45 NOK -11.19% Market Closed
Market Cap: 261.9m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bergenbio ASA
Income from Continuing Operations Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Income from Continuing Operations
-kr155.4m
CAGR 3-Years
21%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Income from Continuing Operations
-kr121.2m
CAGR 3-Years
-2%
CAGR 5-Years
-8%
CAGR 10-Years
-12%
L
Lytix Biopharma AS
OSE:LYTIX
Income from Continuing Operations
-kr87.9m
CAGR 3-Years
-28%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Income from Continuing Operations
kr14.6m
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Income from Continuing Operations
-$37.9m
CAGR 3-Years
N/A
CAGR 5-Years
-50%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Income from Continuing Operations
-kr18.7m
CAGR 3-Years
64%
CAGR 5-Years
45%
CAGR 10-Years
7%

See Also

What is Bergenbio ASA's Income from Continuing Operations?
Income from Continuing Operations
-155.4m NOK

Based on the financial report for Jun 30, 2024, Bergenbio ASA's Income from Continuing Operations amounts to -155.4m NOK.

What is Bergenbio ASA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
4%

Over the last year, the Income from Continuing Operations growth was 40%. The average annual Income from Continuing Operations growth rates for Bergenbio ASA have been 21% over the past three years , 4% over the past five years .

Back to Top